World Influenza Vaccines Therapeutics Market Analysed by iGATE Research in Topical Research Study Available at

29 Feb 2016 • by Natalie Aster

LONDON – In the worldwide vaccines marketplace, influenza vaccine represents one of the most lucrative segments. Influenza (otherwise known as flu) is an extremely contagious disease and usually has the most severe effect on children and the aged. Influenza viruses are deemed as a leading cause of morbidity and mortality for patients globally. The extensive population base along with considerably low immunisation coverage in emerging marketplaces, increasing government support for immunisation and soaring awareness of the role of influenza vaccine in disease prevention are the important factors that are expect to fuel the growth of the influenza vaccines market. 

Geography-wise, the USA grabs the majority of the market share of the in the influenza vaccines market. Japan is the 2nd dominant market for influenza vaccines as of 2015. China and India are the 3rd and 4th leading markets for influenza vaccines. Amid the others significant markets for this disease one can name Brazil, Germany, France, the UK, Italy, Spain and South Korea.

Sanofi Pasteur's Fluzone captures the lion’s share of the market, with Novartis’s Fluvirin/Flucelvax following after. GSK’s Fluarix/FluLaval captures the 3rd biggest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax hold, respectively, the 4th and 5th positions in the influenza vaccines market, whilst Flublok has captured the smallest market share.

Topical market research report “Influenza Vaccines Market and Forecast - Global Analysis” created by iGATE Research provides an all-round analysis of the world influenza vaccines market. The study presents a detailed market share analysis (historical and forecast) by country. It covers a geographical distribution, covering the number of persons vaccinated with influenza vaccines in the respective country with forecasts as well as extensive analyses for the top 25 national markets. The report provides sales figures for the word’s 7 leading influenza vaccines brands along with detailed forecasts for the same. A comprehensive analysis of the major deals, such as M&As and licensing agreements, is included. The study also identifies and canvasses key drivers and challenges in the worldwide market for influenza vaccines.  Historical data are available for 2011-2015 and forecast figures are offered through to 2021.

Report Details:

Influenza Vaccines Market and Forecast - Global Analysis
Published: February, 2016
Pages: 176
Price: US$ 1,400.00 

More insightful studies can be found at iGATE Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970